Syros Pharmaceuticals, Inc. Contracts & Agreements

64 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Forms of Tyme Support Agreement
Syros Pharmaceuticals, Inc.
Biotechnology
DE
2022
Fifth Amendment to Loan and Security Agreement, dated December 4, 2024, by and among Syros Pharmaceuticals, Inc. and Oxford Finance LLC, as collateral agent and lender
Loan Agreements
Syros Pharmaceuticals, Inc.
2024
Amended and Restated Director Compensation Policy
Compensation Agreements
Syros Pharmaceuticals, Inc.
2024
Separation Agreement, dated October 16, 2023, by and between the Registrant and Eric. R. Olson, Ph.D
Separation Agreements
Syros Pharmaceuticals, Inc.
2024
Description of Securities Registered under Section 12 of the Exchange Act
Syros Pharmaceuticals, Inc.
2024
Form of Pre-Funded Warrant
Warrant Agreements
Syros Pharmaceuticals, Inc.
2023
Underwriting Agreement, dated December 18, 2023, by and among Syros Pharmaceuticals, Inc., Cowen and Company, LLC and Piper Sandler & Co
Underwriting Agreements
Syros Pharmaceuticals, Inc.
2023
Amended and Restated Offer Letter, dated September 28, 2023, by and between the Registrant and Conley Chee
Syros Pharmaceuticals, Inc.
2023
Retirement and Transition Agreement, dated September 28, 2023, by and between the Registrant and Nancy Simonian, M.D
Retirement Agreements
Syros Pharmaceuticals, Inc.
2023
Form of Stock Option Agreement Under 2022 Equity Incentive Plan
Bonus & Incentive Agreements
Syros Pharmaceuticals, Inc.
Biotechnology
2022
Second Amendment to Loan and Security Agreement, dated August 31, 2022, by and among the Registrant and Oxford Finance LLC, as collateral agent and lender
Loan Agreements
Syros Pharmaceuticals, Inc.
2022
Form of Restricted Stock Unit Agreement Under 2022 Equity Incentive Plan
Bonus & Incentive Agreements
Syros Pharmaceuticals, Inc.
Biotechnology
2022
Form of Restricted Stock Agreement Under 2022 Equity Incentive Plan
Bonus & Incentive Agreements
Syros Pharmaceuticals, Inc.
2022
Syros Pharmaceuticals, Inc. Amended and Restated Director Compensation Policy
Compensation Agreements
Syros Pharmaceuticals, Inc.
2022
Form of Syros Pharmaceuticals, Inc. 2022 Equity Incentive Plan
Bonus & Incentive Agreements
Syros Pharmaceuticals, Inc.
2022
Form of Pre-Funded Warrant
Warrant Agreements
Syros Pharmaceuticals, Inc.
Biotechnology
NY
2022
Amendment to Loan and Security Agreement, dated July 3, 2022, by and among Syros Pharmaceuticals, Inc. and Oxford Finance LLC, as collateral agent and lender
Loan Agreements
Syros Pharmaceuticals, Inc.
Biotechnology
NY
2022
Registration Rights Agreement, dated July 3, 2022, by and among Syros Pharmaceuticals, Inc., 667, L.P. and Baker Brothers Life Sciences, L.P
Registration Rights Agreements
Syros Pharmaceuticals, Inc.
Biotechnology
NY
2022
Registration Rights Agreement, dated July 3, 2022, by and among Syros Pharmaceuticals, Inc. and the persons party thereto
Registration Rights Agreements
Syros Pharmaceuticals, Inc.
2022
Securities Purchase Agreement, dated July 3, 2022, by and among Syros Pharmaceuticals, Inc. and the persons party thereto
Purchase Agreements
Syros Pharmaceuticals, Inc.
Biotechnology
DE
2022
Form of Lock-up Agreement
Syros Pharmaceuticals, Inc.
Biotechnology
2022
Form of Syros Support Agreement
Syros Pharmaceuticals, Inc.
2022
Form of Warrant to Purchase Common Stock or Pre-Funded Warrants
Warrant Agreements
Syros Pharmaceuticals, Inc.
2022
Agreement and Plan of Merger, dated July 3, 2022, by and among Syros Pharmaceuticals, Inc., Tack Acquisition Corp. and Tyme Technologies, Inc
Merger Agreements
Syros Pharmaceuticals, Inc.
2022
Master Collaboration Agreement dated March 7, 2022 between Syros Pharmaceuticals, Inc. and QIAGEN Manchester Limited
Collaboration Agreements
Syros Pharmaceuticals, Inc.
Biotechnology
NY
2022
Description of Securities Registered under Section 12 of the Exchange Act
Syros Pharmaceuticals, Inc.
Biotechnology
2022
2022 Inducement Stock Incentive Plan
Bonus & Incentive Agreements
Syros Pharmaceuticals, Inc.
Biotechnology
DE
2022
Form of Nonstatutory Stock Option Agreement under 2022 Inducement Stock Incentive Pla
Bonus & Incentive Agreements
Syros Pharmaceuticals, Inc.
2022
Form of Restricted Stock Unit Agreement under 2022 Inducement Stock Incentive Plan
Bonus & Incentive Agreements
Syros Pharmaceuticals, Inc.
Biotechnology
DE
2022
Offer Letter, effective September 27, 2021, between Syros Pharmaceuticals, Inc. and Conley Chee
Syros Pharmaceuticals, Inc.
Biotechnology
MA
2021
Form of Nonstatutory Stock Option Agreement for Inducement Awards
Stock Agreements
Syros Pharmaceuticals, Inc.
Biotechnology
DE
2021
Offer Letter, effective October 12, 2021, between Syros Pharmaceuticals, Inc. and Jason Haas
Syros Pharmaceuticals, Inc.
Biotechnology
MA
2021
Amendment No. 1 to Amended and Restated Cancer License Agreement, dated January 8, 2021, by and between the Registrant and TMRC Co., Ltd
License Agreements
Syros Pharmaceuticals, Inc.
2021
Description of Securities Registered under Section 12 of the Exchange Act
Syros Pharmaceuticals, Inc.
Biotechnology
2021
Underwriting Agreement, dated January 19, 2021, by and among Syros Pharmaceuticals, Inc., Cowen and Company, LLC and Piper Sandler & Co., as representatives of the several...
Underwriting Agreements
Syros Pharmaceuticals, Inc.
2021
Registration Rights Agreement, dated December 4, 2020, by and among Syros Pharmaceuticals, Inc. and the persons party thereto
Registration Rights Agreements
Syros Pharmaceuticals, Inc.
Biotechnology
DE
2020
Securities Purchase Agreement, dated December 4, 2020, by and among Syros Pharmaceuticals, Inc. and the persons party thereto
Purchase Agreements
Syros Pharmaceuticals, Inc.
Biotechnology
DE
2020
Form of Pre-Funded Warrant
Warrant Agreements
Syros Pharmaceuticals, Inc.
2020
Form of Warrant to Purchase Common Stock or Pre-Funded Warrants
Warrant Agreements
Syros Pharmaceuticals, Inc.
2020
Asset Purchase Agreement, dated as of December 4, 2020, by and between Syros Pharmaceuticals, Inc. and Orsenix, LLC
Purchase Agreements
Syros Pharmaceuticals, Inc.
Biotechnology
GA
2020
Description of Securities Registered under Section 12 of the Exchange Act
Syros Pharmaceuticals, Inc.
Biotechnology
2020
Offer Letter dated April 24, 2013 by and between the Registrant and Eric R. Olson, Ph.D
Syros Pharmaceuticals, Inc.
Biotechnology
MA
2020
Letter Agreement dated November 18, 2019 by and between the Registrant and Incyte Corporation
Syros Pharmaceuticals, Inc.
Biotechnology
2020
License and Collaboration Agreement dated December 17, 2019 by and between the Registrant and Global Blood Therapeutics, Inc
Collaboration Agreements
Syros Pharmaceuticals, Inc.
Biotechnology
DE
2020
Loan and Security Agreement, dated February 12, 2020, by and among Syros Pharmaceuticals, Inc. and Oxford Finance LLC, as collateral agent and lender
Loan Agreements
Syros Pharmaceuticals, Inc.
Biotechnology
NY
2020
Consulting Agreement dated August 8, 2012 between the Registrant and Richard A. Young, Ph.D., as amended
Consulting Agreements
Syros Pharmaceuticals, Inc.
Biotechnology
MA
2019
Lease Termination Agreement dated as of November 1, 2019 between Syros Pharmaceuticals, Inc. and 620 Memorial Leasehold LLC
Lease Agreements
Syros Pharmaceuticals, Inc.
2019
Underwriting Agreement relating to the Common Offering, dated April 5, 2019, by and among Syros Pharmaceuticals, Inc., Cowen and Company, LLC and Piper Jaffray & Co., as...
Underwriting Agreements
Syros Pharmaceuticals, Inc.
2019
Underwriting Agreement relating to the Preferred Offering, dated April 5, 2019, by and among Syros Pharmaceuticals, Inc., Cowen and Company, LLC and Piper Jaffray & Co., as...
Underwriting Agreements
Syros Pharmaceuticals, Inc.
2019
Form of Class A Warrant
Warrant Agreements
Syros Pharmaceuticals, Inc.
2019
Form of Series A Convertible Preferred Stock Certificate
Stock Agreements
Syros Pharmaceuticals, Inc.
Biotechnology
2019
Amended and Restated Cancer License Agreement dated April 28, 2016 by and between the Registrant and TMRC Co., Ltd
License Agreements
Syros Pharmaceuticals, Inc.
Biotechnology
CA
2019
Form of Restricted Stock Unit Agreement under 2016 Stock Incentive Plan
Bonus & Incentive Agreements
Syros Pharmaceuticals, Inc.
2019
Lease dated January 8, 2019 between the Company and DIV 35 CPD, LLC
Lease Agreements
Syros Pharmaceuticals, Inc.
2019
Offer Letter effective March 12, 2018 between Syros Pharmaceuticals, Inc. and Joseph J. Ferra, Jr
Syros Pharmaceuticals, Inc.
Biotechnology
MA
2018
Target Discovery, Research Collaboration and Option Agreement dated January 8, 2018 by and between the Registrant and Incyte Corporation
Collaboration Agreements
Syros Pharmaceuticals, Inc.
Biotechnology
DE
2018
Offer Letter dated November 6, 2017 by and between the Registrant and Jeremy Springhorn, Ph.D
Syros Pharmaceuticals, Inc.
2018
Stock Purchase Agreement dated January 8, 2018 by and between the Registrant and Incyte Corporation, as amended
Stock Agreements
Syros Pharmaceuticals, Inc.
2018
Underwriting Agreement, dated January 30, 2018, by and among Syros Pharmaceuticals, Inc., J.P. Morgan Securities LLC, Cowen and Company, LLC and Piper Jaffray & Co., as...
Underwriting Agreements
Syros Pharmaceuticals, Inc.
Biotechnology
NY
2018
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
Syros Pharmaceuticals, Inc.
Biotechnology
NY
2017
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
Syros Pharmaceuticals, Inc.
2017
CONSULTING AGREEMENT
Consulting Agreements
Syros Pharmaceuticals, Inc.
2017
- 1 -
Syros Pharmaceuticals, Inc.
Biotechnology
MA
2017
[Number of Shares] SYROS PHARMACEUTICALS, INC. Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
Syros Pharmaceuticals, Inc.
Biotechnology
NY
2016